An article on bioterrorism legislation in the Dec. 17, 2001, issue of BioWorld Today should have said companies with less than $750 million (not $750,000) in paid-in capital would receive a refund for net operating losses to fund the research, under a bill proposed by Sen. Joe Lieberman.

Editor¿s Note: The correction will be made today in BioWorld Online.